Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05074472
What this trial is testing

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more
ZielBio, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT03006302
What this trial is testing

Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 41
Not applicableUnknownNCT05400681
What this trial is testing

Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
Sonke Detlefsen 200
Not applicableNot Yet RecruitingNCT07799298
What this trial is testing

Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Who this might be right for
Pancreatic CancerPancreatectomyAdenocarcinoma Pancreas
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 360
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Not applicableStudy completedNCT07104864
What this trial is testing

Early Detection of PDAC in Patients With Chronic Pancreatitis

Who this might be right for
Chronic PancreatitisPDAC - Pancreatic Ductal Adenocarcinoma
First Affiliated Hospital Xi'an Jiaotong University 359
Very early researchActive Not RecruitingNCT05365893
What this trial is testing

PHL Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fox Chase Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT02261714
What this trial is testing

Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Resected
Targovax ASA 32
Not applicableLooking for participantsNCT04136132
What this trial is testing

Prospective Monocentric Clinical-biological Database

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 120
Very early researchUnknownNCT05277987
What this trial is testing

An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects

Who this might be right for
CAR T-Cell Therapy
Shenzhen Fifth People's Hospital 18
Early research (Phase 1)UnknownNCT03703063
What this trial is testing

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT07076212
What this trial is testing

Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
Medical University of South Carolina 52
Large-scale testing (Phase 3)Looking for participantsNCT05254171
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV
Panbela Therapeutics, Inc. 600
Testing effectiveness (Phase 2)Temporarily pausedNCT04090463
What this trial is testing

IORT on Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Cancer
Universita di Verona 100
Early research (Phase 1)Study completedNCT04050085
What this trial is testing

SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRefractory Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
University of California, Davis 6
Not applicableStudy completedNCT05476978
What this trial is testing

Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatitis, ChronicPancreatic Neuroendocrine Tumor+1 more
Huazhong University of Science and Technology 130
Early research (Phase 1)Study completedNCT01908478
What this trial is testing

Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cedars-Sinai Medical Center 34
Not applicableNot Yet RecruitingNCT07064447
What this trial is testing

Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator

Who this might be right for
CholangiocarcinomaCholangiopathyBiliary Stricture+2 more
Germans Trias i Pujol Hospital 260
Testing effectiveness (Phase 2)UnknownNCT01971281
What this trial is testing

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Who this might be right for
Pancreatic Adenocarcinoma
NovoCure Ltd. 40
Early research (Phase 1)Active Not RecruitingNCT05539430
What this trial is testing

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more
Legend Biotech USA Inc 56
Next Page